BACKGROUND: Neurological outcome and mortality of patients suffering from poor grade subarachnoid hemorrhage (SAH) may have changed over time. Several factors, including patients' characteristics, the presence of hydrocephalus and intraparenchymal hematoma, might also contribute to this effect. The aim of this study was to assess the temporal changes in mortality and neurologic outcome in SAH patients and identify their predictors. METHODS: We performed a single center retrospective cohort study from 2004 to 2018. All non-traumatic SAH patients with poor grade on admission (WFNS score of 4 or 5) who remained at least 24 h in the hospital were included. Time course was analyzed into four groups according to the years of admission (2004-2007; 2008-2011; 2012-2015 and 2016-2018). RESULTS: A total of 353 patients were included in this study: 202 patients died (57 %) and 260 (74 %) had unfavorable neurological outcome (UO) at 3 months. Mortality tended to decrease in in 2008-2011 and 2016-2018 periods (HR 0.55 [0.34-0.89] and HR 0.33 [0.20-0.53], respectively, when compared to 2004-2007). The proportion of patients with UO remained high and did not vary significantly over time. Patients with WFNS 5 had higher mortality (68 % vs. 34 %, p = 0.001) and more frequent UO (83 % vs. 54 %, p = 0.001) than those with WFNS 4. In the multivariable analysis, WFNS 5 was independently associated with mortality (HR 2.12 [1.43-3.14]) and UO (OR 3.23 [1.67-6.25]). The presence of hydrocephalus was associated with a lower risk of mortality (HR 0.60 [0.43-0.84]). CONCLUSIONS: Both hospital mortality and UO remained high in poor grade SAH patients. Patients with WFNS 5 on admission had worse prognosis than others; this should be taken into consideration for future clinical studies.
BACKGROUND: Neurological outcome and mortality of patients suffering from poor grade subarachnoid hemorrhage (SAH) may have changed over time. Several factors, including patients' characteristics, the presence of hydrocephalus and intraparenchymal hematoma, might also contribute to this effect. The aim of this study was to assess the temporal changes in mortality and neurologic outcome in SAHpatients and identify their predictors. METHODS: We performed a single center retrospective cohort study from 2004 to 2018. All non-traumatic SAHpatients with poor grade on admission (WFNS score of 4 or 5) who remained at least 24 h in the hospital were included. Time course was analyzed into four groups according to the years of admission (2004-2007; 2008-2011; 2012-2015 and 2016-2018). RESULTS: A total of 353 patients were included in this study: 202 patientsdied (57 %) and 260 (74 %) had unfavorable neurological outcome (UO) at 3 months. Mortality tended to decrease in in 2008-2011 and 2016-2018 periods (HR 0.55 [0.34-0.89] and HR 0.33 [0.20-0.53], respectively, when compared to 2004-2007). The proportion of patients with UO remained high and did not vary significantly over time. Patients with WFNS 5 had higher mortality (68 % vs. 34 %, p = 0.001) and more frequent UO (83 % vs. 54 %, p = 0.001) than those with WFNS 4. In the multivariable analysis, WFNS 5 was independently associated with mortality (HR 2.12 [1.43-3.14]) and UO (OR 3.23 [1.67-6.25]). The presence of hydrocephalus was associated with a lower risk of mortality (HR 0.60 [0.43-0.84]). CONCLUSIONS: Both hospital mortality and UO remained high in poor grade SAHpatients. Patients with WFNS 5 on admission had worse prognosis than others; this should be taken into consideration for future clinical studies.
Authors: G M Teasdale; C G Drake; W Hunt; N Kassell; K Sano; B Pertuiset; J C De Villiers Journal: J Neurol Neurosurg Psychiatry Date: 1988-11 Impact factor: 10.154
Authors: Jantien Hoogmoed; Airton L de Oliveira Manoel; Bert A Coert; Thomas R Marotta; R Loch Macdonald; W Peter Vandertop; Dagmar Verbaan; Menno R Germans Journal: World Neurosurg Date: 2019-08-06 Impact factor: 2.104
Authors: J Mocco; Evan R Ransom; Ricardo J Komotar; J Michael Schmidt; Robert R Sciacca; Stephan A Mayer; E Sander Connolly Journal: Neurosurgery Date: 2006-09 Impact factor: 4.654
Authors: Carlina E van Donkelaar; Nicolaas A Bakker; Nic J G M Veeger; Maarten Uyttenboogaart; Jan D M Metzemaekers; Omid Eshghi; Aryan Mazuri; Mahrouz Foumani; Gert-Jan Luijckx; Rob J M Groen; J Marc C van Dijk Journal: J Neurosurg Date: 2016-04-01 Impact factor: 5.115
Authors: Michelle H Chua; Christoph J Griessenauer; Christopher J Stapleton; Lucy He; Ajith J Thomas; Christopher S Ogilvy Journal: Stroke Date: 2016-02-02 Impact factor: 7.914
Authors: Sarah E Nelson; Jose I Suarez; Alexander Sigmon; Jun Hua; Casey Weiner; Haris I Sair; Robert D Stevens Journal: Neurol Res Pract Date: 2022-06-27